BioSyent Inc. is a specialty pharmaceutical company. The Company, through its subsidiary, BioSyent Pharma Inc., sources, acquires or in-licenses pharmaceutical products and markets these products in Canada. Through its subsidiary, Hedley Technologies Ltd., the Company also operates legacy business marketing bio and non-chemical insecticides. Its products include FeraMAX 150, Cathejell, FeraMAX Powder, RepaGyn, Proktis-M and Aguettant System. FeraMAX 150 is an oral hematinic indicated for the prevention and treatment of iron deficiency anemia (IDA). Cathejell is indicated for surface anesthesia and lubrication for various procedures, including male and female cystoscopies, catheterizations and other endourethral operations; endoscopies, proctoscopies, rectoscopies, and tracheal intubations. RepaGyn is a vaginal suppository, which helps relieve dryness and helps to promote healing of vaginal mucosa. Proktis-M rectal suppository is designed to help healing of the anus and rectum.